Research undertaken in the Department of Pathology and Laboratory Medicine combines talent, creativity and resources, to understand the causes of disease and develop treatments for infectious diseases, diabetes, obesity and lipid disorders, cancer and cardiovascular diseases.
Researchers of the department, along with industry and community partners, collaborate to bring forth cutting-edge research that leads to discovery of novel technologies and therapeutics for treating a society afflicted with these diseases.
To inquire into specific laboratories and their goals, please refer to each research faculty’s biography.
Research News/ Events
Davidson Named to NIH Study Section
Sean Davidson, PhD, professor in the pathology and laboratory medicine department, has been selected to serve as a member of the Integrative Nutrition and Metabolic Processes Study Section of the Center for Scientific Review at the National Institutes of Health. He will serve in this role from July 1, 2012, through June 30, 2015.
As a member of the Study Section, Davidson will aid in review of grant applications, make recommendations on these applications and survey the status of research in his field of science.
Target for Diabetes Drug Identified
Patrick Tso, PhD, professor in the UC Department of Pathology and Laboratory Medicine, has revealed that apolipoprotein A-IV (apoA-IV) is secreted by the small intestine in response to fat absorption. Researchers have shed light on a naturally produced protein, which could be used as a potential target for a new diabetes therapeutic. Read full article.....
Woollett Awarded Grant to Study Relationship Between Maternal Cholesterol and Fetal Growth
Laura Woollett, PhD, professor in the UC Department of Pathology, has been awarded a $100,000 Grand Challenges Explorations grant through the Bill & Melinda Gates Foundation, for a study of maternal cholesterol and its connection to fetal growth.
She will partner with Andrew Prentice, PhD, and Sophie Moore, PhD, of the MRC International Nutrition Group in The Gambia, for a project titled the MRC International Nutrition Group in The Gambia for a project titled "Improving Fetal Growth Rates in Developing Countries.” Together, they will work to determine whether or not cholesterol is actually a beneficial factor that helps a fetus to grow normally during gestation. Read full article....